Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the disruption of nerve signals and various associated neurological symptoms, ranging from vision problems to numbness, ...

"Seventeen of the patients in our study had brain pathology available, all of whom had findings typical of multiple sclerosis. Immunopathological phenotyping was performed in 13 patients, all of whom ...

Multiple sclerosis (MS) is a complex and unpredictable disease that affects the central nervous system. It is the most common neurologic disease of young adults, usually diagnosed between the ages of ...

An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the ...

Multiple sclerosis (MS), characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease. But the ...

Research shows changes in the gut bacteria of multiple sclerosis patients compared with healthy controls. There are also microbiota differences between multiple sclerosis activity states. Researchers ...

People with multiple sclerosis exhibit variable degrees of remyelination. Individuals with greater capacity to remyelinate seem to have less clinical disability, thereby fuelling the research to find ...

Traci Albuck has relapsing remitting multiple sclerosis (RRMS), characterized by unpredictable relapses where new symptoms appear, or existing ones worsen, ...

ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.

The association between multiple sclerosis and a diet focusing on fresh produce, fish, and olive oil is particularly strong ...

The French pharmaceutical company said an FDA review for tolebrutinib would extend beyond the Dec. 28 target. - gonzalo fuentes/Reuters Sanofi shares fell after an experimental treatment for multiple ...